Lynx Dx, a leader in innovative diagnostic solutions, announces the publication of a comprehensive analytical validation ...
Mr Charles, 67, was diagnosed with an aggressive form of the disease shortly after retiring as a risk manager in nuclear and ...
A near-unanimous 94 per cent of GPs say the Government should roll out the life-saving checks (pictured, file photo), ...
Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease who are eligible to receive the drug.
Results from a new Phase 3 trial published in the journal npj Precision Oncology found that a cancer stem cell test can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results